Jeff Chamberlain

Jeff Chamberlain has a diverse work experience in the biotech and life sciences industries. Jeff is currently the Director of Biopharma Partnerships at RareCyte, Inc. starting in 2023. Previously, they worked at Synthego Corporation from 2018 to 2022, where they held various roles including Regional Sales Manager, Senior Strategic Account Manager, and Strategic Account Manager. At Synthego, they led a sales team, collaborated on cross-functional committees, and contributed to commercial strategy and implementation projects. From 2014 to 2018, they worked at Pacific Biomarkers as the Director of Business Development and Associate Scientist, Business Development. Jeff was responsible for building and overseeing business relationships with companies sponsoring clinical research and development projects. Before that, they were the Project Lead and Manager of Business Development at Zwitter Technology from 2012 to 2014, where they led a team in technical product development and grant projects. Jeff also worked as a Consultant at Peyvan Systems, Inc. from 2013 to 2014. Additionally, they served as the President and President Emeritus of the Science & Engineering Business Association (SEBA) from 2010 to 2012.

Jeff Chamberlain pursued their education starting in 2003 when they enrolled at Vanderbilt University. Jeff completed their Bachelor's degree in Biomedical Engineering with Honors in 2007.

Jeff furthered their studies at the University of Washington - School of Medicine from 2007 to 2012, where they obtained a PhD in Bioengineering. During this time, they focused on developing their expertise in the field of Bioengineering.

In addition to their PhD, Jeff also pursued a Certificate in Technology Entrepreneurship at the University of Washington - Michael G. Foster School of Business. Jeff obtained this certificate from 2009 to 2012, which suggests they sought to enhance their understanding of the business aspects of the technology industry.